Prospective Multicenter Observation Study on the Serial Changes in Ventriculo-ventricular Conduction Times According to Cardiac-resynchronization Therapy Response

Samsung Medical Center6 sites in 1 country100 target enrollmentJuly 20, 2018

ConditionsHeart Failure

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Heart Failure
Sponsor: Samsung Medical Center
Enrollment: 100
Locations: 6
Primary Endpoint: Serial change of ventriculo-ventricular conduction times
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This prospective multicenter registry study aims to detect the serial changes in ventriculo-ventricular conduction times according to cardiac-resynchronization therapy response.

Registry

clinicaltrials.gov

Start Date

July 20, 2018

End Date

July 20, 2024

Last Updated

4 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Samsung Medical Center

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•meeting the current ESC or ACCF/AHA/HRS Class I or Class IIa indications for cardiac-resynchronization (CRT) implant

Exclusion Criteria

•Myocardial infarction, unstable angina within 40 days prior the enrollment
•Recent cardiac revascularization in the 4 weeks prior to the enrollment or planned for the 3 months following
•Cerebrovascular accident (CVA) or transient ischemic attack (TIA) in the 3 months prior to the enrollment
•Primary valvular disease requiring surgical correction
•Pregnant or are planning during the duration of the investigation
•Status 1 candidate for cardiac transplantation or consideration for transplantation over the next 12 months
•Post-cardiac transplantation
•Life expectancy \< 12 months
•Currently participating in any other clinical investigation except for observational registry